W
Wei Shen Lim
Researcher at Nottingham University Hospitals NHS Trust
Publications - 132
Citations - 19978
Wei Shen Lim is an academic researcher from Nottingham University Hospitals NHS Trust. The author has contributed to research in topics: Community-acquired pneumonia & Pneumonia. The author has an hindex of 38, co-authored 113 publications receiving 15523 citations. Previous affiliations of Wei Shen Lim include University of Nottingham & Nottingham City Hospital.
Papers
More filters
Journal ArticleDOI
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby,Marion K Campbell,Enti Spata,Jonathan Emberson,Natalie Staplin,Guilherme Pessoa-Amorim,Leon Peto,Martin Wiselka,L Wiffen,Simon Tiberi,B Caplin,C Wroe,Carole Green,Paul Hine,B Prudon,T George,A Wight,J K Baillie,Buddha Basnyat,Maya H Buch,Lucy C Chappell,Jeremy N. Day,Saul N. Faust,Raph L. Hamers,Thomas Jaki,Edmund Juszczak,Katie Jeffery,Wei Shen Lim,Alan A Montgomery,Andrew D Mumford,Kathy Rowan,G Thwaites,M Mafham,Richard Haynes,Martin J Landray +34 more
TL;DR: In this paper, the authors evaluated the effects ofcilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation, and found that the drug improved survival and other clinical outcomes.
Journal ArticleDOI
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).
Jonathan S. Nguyen-Van-Tam,Peter J. M. Openshaw,Ahmed Hashim,Elaine M. Gadd,Wei Shen Lim,Malcolm G Semple,Robert C. Read,Bruce Taylor,Stephen J. Brett,Jim McMenamin,Joanne E. Enstone,Colin Armstrong,K G Nicholson +12 more
TL;DR: Findings support the use of pandemic vaccine in pregnant women, children <5 years of age and those with chronic lung disease, especially in patients who are recorded as obese or who have pulmonary conditions other than asthma or COPD.
Posted ContentDOI
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Peter Horby,Guilherme Pessoa-Amorim,Leon Peto,Christopher E. Brightling,Rahuldeb Sarkar,Karen Thomas,V Jeebun,Abdul Ashish,R Tully,David Chadwick,M Sharafat,Richard B. Stewart,B Rudran,Kenneth Baillie,Maya H Buch,Lucy C Chappell,Jeremy N. Day,S Furst,Thomas Jaki,Katie Jeffery,Edmund Juszczak,Wei Shen Lim,Alan A Montgomery,Andrew D Mumford,Kathy Rowan,G Thwaites,M Mafham,Richard Haynes,Martin J Landray +28 more
TL;DR: In this article, the authors evaluated the safety and efficacy of tocilizumab in adult patients admitted to hospital with COVID-19 with evidence of both hypoxia and systemic inflammation.
Journal ArticleDOI
Severity prediction rules in community acquired pneumonia : a validation study
TL;DR: The value of three of the four factors used in the mBTSr as predictors of mortality is confirmed and did not perform as well in this validation study which included a high proportion of elderly patients compared with the derivation studies.
Posted ContentDOI
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.
Peter Horby,M Mafham,Louise Linsell,Jennifer L Bell,Natalie Staplin,Jonathan Emberson,Martin Wiselka,Andrew Ustianowski,E Elmahi,B Prudon,A Whitehouse,Timothy Felton,John Williams,J Faccenda,Jonathan Underwood,J K Baillie,Lucy C Chappell,Saul N. Faust,Thomas Jaki,Katie Jeffery,Wei Shen Lim,Alan A Montgomery,Kathy Rowan,Joel Tarning,James A Watson,Nicholas J. White,Edmund Juszczak,Richard Haynes,Martin J Landray +28 more
TL;DR: In patients hospitalized with COVID-19, hydroxychloroquine was not associated with reductions in 28-day mortality but was associated with an increased length of hospital stay and increased risk of progressing to invasive mechanical ventilation or death.